Long-term BRCA1 down-regulation by small hairpin RNAs targeting the 3′ untranslated region

Neoplasma

Volumn 55, Issue 2, 2008, Pages 130-137

  Vondruskova, E ^a   Malik, R ^b   Sevcik, J ^a   Kleiblova, P ^a   Kleibl, Z ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

BRCA1; Retroviral infection; RNAi; shRNA; UTR

Indexed keywords

BRCA1 PROTEIN; MESSENGER RNA; SHORT HAIRPIN RNA; SMALL INTERFERING RNA;

3' UNTRANSLATED REGION; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RETROVIRUS INFECTION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; PHYSIOLOGY; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

3' UNTRANSLATED REGIONS; CELL LINE, TUMOR; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BRCA1; HUMANS; RNA, SMALL INTERFERING;

EID: 48549102105     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. VENKITARAMAN AR. Functions of BRCA1 and BRCA2 in the biological response to DNA damage. J Cell Sci 2001; 114: 3591-3598. (Pubitemid 33041041)
2. PAGEAU GJ, HALL LL, LAWRENCE JB. BRCA1 does not paint the inactive X to localize XIST RNA but may contribute to broad changes in cancer that impact XIST and Xi heterochromatin. J Cell Biochem 2007; 100: 835-850.
3. EASTMAN A. Cell cycle checkpoints and their impact on anticancer therapeutic strategies. J Cell Biochem 2004; 91: 223-231.
4. MULLAN PB, QUINN JE, HARKIN DP. The role of BRCA1 in transcriptional regulation and cell cycle control. Oncogene 2006; 25: 5854-5863. (Pubitemid 44453441)
5. ANDREWS HN, MULLAN PB, McWILLIAMS S et al. BRCA1 regulates the interferon gamma-mediated apoptotic response. J Biol Chem 2002; 277: 26225-26232.
6. SANKARAN S, STARITA LM, GROEN AC et al. Centrosomal microtubule nucleation activity is inhibited by BRCA1-dependent ubiquitination. Mol Cell Biol 2005; 25: 8656-8668.
7. SANKARAN S, STARITA LM, SIMONS AM et al. Identification of domains of BRCA1 critical for the ubiquitin-dependent inhibition of centrosome function. Cancer Res 2006; 66: 4100-4107.
8. BOULTON SJ. BRCA1-mediated ubiquitylation. Cell Cycle 2006; 5: 1481-1486.
9. MANKE IA, LOWERY DM, NGUYEN A et al. BRCT repeats as phosphopeptide- binding modules involved in protein targeting. Science 2003; 302: 636-639.
10. MIKI Y, SWENSEN J, SHATTUCK-EIDENS D et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66-71. (Pubitemid 24345325)
11. LEVY-LAHAD E, FRIEDMAN E. Cancer risks among BRCA1 and BRCA2 mutation carriers. Br J Cancer 2007; 96: 11-15. (Pubitemid 46094632)
12. CARVALHO MA, COUCH FJ, MONTEIRO AN. Functional assays for BRCA1 and BRCA2. Int J Biochem Cell Biol 2007; 39: 298-310.
13. TOMARI Y, ZAMORE PD. Perspective: machines for RNAi. Genes Dev 2005; 19: 517-529.
14. HUTVAGNER G, MCLACHLAN J, PASQUINELLI AE et al. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 2001; 293: 834-838.
15. SCHOLZOVA E, MALIK R, SEVCIK J et al. RNA regulation and cancer development. Cancer Lett 2007; 246: 12-23.
16. JACKSON RJ, STANDART N. How do microRNAs regulate gene expression? Sci STKE 2007; 2007: re1.
17. HOLEN T, AMARZGUIOUI M, WIIGER MT et al. Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor. Nucleic Acids Res 2002; 30: 1757-1766.
18. OMI K, TOKUNAGA K, HOHJOH H. Long-lasting RNAi activity in mammalian neurons. FEBS Lett 2004; 558: 89-95.
19. SILVA JM, LI MZ, CHANG K et al. Second-generation shRNA libraries covering the mouse and human genomes. Nat Genet 2005; 37: 1281-1288.
20. BRUMMELKAMP TR, BERNARDS R, AGAMI R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296: 550-553. (Pubitemid 34408678)
21. MIYAGISHI M, TAIRA K. RNAi expression vectors in mammalian cells. Methods Mol Biol 2004; 252: 483-491.
22. LI CX, PARKER A, MENOCAL E et al. Delivery of RNA interference. Cell Cycle 2006; 5: 2103-2109.
23. WIZNEROWICZ M, SZULC J, TRONO D. Tuning silence: conditional systems for RNA interference. Nat Methods 2006; 3: 682-688. (Pubitemid 44275734)
24. JACKSON AL, BURCHARD J, SCHELTER J ET AL. Widespread siRNA "off-target" transcript silencing mediated by seed region sequence complementarity. RNA 2006; 12: 1179-1187.
25. BIRMINGHAM A, ANDERSON EM, REYNOLDS A et al. 3' UTR seed matches, but not overall identity, are associated with RNAi off-targets. Nat Methods 2006; 3: 199-204.
26. WHITHER RNAI? Nat Cell Biol 2003; 5: 489-490.
27. CULLEN BR. Enhancing and confirming the specificity of RNAi experiments. Nat Methods 2006; 3: 677-681.
28. KIMCHI-SARFATY C, OH JM, KIM IW et al. A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science 2007; 315: 525-528.
29. DICKINS RA, HEMANN MT, ZILFOU JT et al. Probing tumor phenotypes using stable and regulated synthetic microRNA precursors. Nat Genet 2005; 37: 1289-1295.
30. PFAFFL MW, HORGAN GW, DEMPFLE L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002; 30: e36.
31. REYNOLDS A, LEAKE D, BOESE Q et al. A Rational siRNA design for RNA interference. Nat Biotechnol 2004; 22: 326-330.
32. PEI Y, TUSCHL T. On the art of identifying effective and specific siRNAs. Nat Methods 2006; 3: 670-676.
33. PATZEL V. In silico selection of active siRNA. Drug Discov Today 2007; 12: 139-148.
34. HUESKEN D, LANGE J, MICKANIN C et al. Design of a genome-wide siRNA library using an artificial neural network. Nat Biotechnol 2005; 23: 995-1001. (Pubitemid 41114034)
35. OLSON A, SHETH N, LEE JS et al. RNAi Codex: a portal/database for short-hairpin RNA (shRNA) gene-silencing constructs. Nucleic Acids Res 2006; 34: D153-D157.
36. KATOH T, SUZUKI T. Specific residues at every third position of siRNA shape its efficient RNAi activity. Nucleic Acids Res 2007; 35: e27.
37. DOENCH JG, SHARP PA. Specificity of microRNA target selection in translational repression. Genes Dev 2004; 18: 504-511.
38. LI LC, OKINO ST, ZHAO H et al. Small dsRNAs induce transcriptional activation in human cells. Proc Natl Acad Sci USA 2006; 103: 17337-17342.
39. KIM DH, VILLENEUVE LM, MORRIS KV et al. Argonaute-1 directs siRNA-mediated transcriptional gene silencing in human cells. Nat Struct Mol Biol 2006; 13: 793-797. (Pubitemid 44338773)
40. JANOWSKI BA, HUFFMAN KE, SCHWARTZ JC et al. Involvement of AGO1 and AGO2 in mammalian transcriptional silencing. Nat Struct Mol Biol 2006; 13: 787-792.
41. VASUDEVAN S, STEITZ JA. AU-Rich-Element-Mediated Upregulation of Translation by FXR1 and Argonaute 2. Cell 2007; 128: 1105-1118.
42. FAN S, YUAN R, MA YX et al. Mutant BRCA1 genes antagonize phenotype of wild-type BRCA1. Oncogene 2001; 20: 8215-8235.
43. HU Y, GHOSH S, AMLEH A et al. Modulation of aromatase expression by BRCA1: a possible link to tissue-specific tumor suppression. Oncogene 2005; 24: 8343-8348.
44. CHRISTOPHOROU MA, RINGSHAUSEN I, FINCH AJ et al. The pathological response to DNA damage does not contribute to p53-mediated tumour suppression. Nature 2006; 443: 214-217.
45. MARTINS CP, BROWN-SWIGART L, EVAN GI. Modeling the therapeutic efficacy of p53 restoration in tumors. Cell 2006; 127: 1323-1334.
46. HOLZEL M, ROHRMOSER M, ORBAN M et al. Rapid conditional knock-down-knock-in system for mammalian cells. Nucleic Acids Res 2007; 35: e17.
47. MA HT, ON KF, TSANG YH et al. An inducible system for expression and validation of the specificity of short hairpin RNA in mammalian cells. Nucleic Acids Res 2007; 35: e22.
48. SHIN KJ, WALL EA, ZAVZAVADJIAN JR et al. A single lentiviral vector platform for microRNA-based conditional RNA interference and coordinated transgene expression. Proc Natl Acad Sci USA 2006; 103: 13759-13764. (Pubitemid 44413981)